<DOC>
	<DOCNO>NCT00871455</DOCNO>
	<brief_summary>Insulin-like growth factor I ( IGF-I ) use measure body 's ability produce growth hormone . Growth hormone important muscle tissue well many tissue body . Growth hormone ( GH ) IGF-I show reduce many person SCI . Baclofen FDA approve drug use treat spasticity . Persons receive long-term baclofen therapy demonstrate increased growth hormone IGF-I level . IGF-I level determine treatment baclofen . In study , investigator determine minimum dose baclofen improvement GH IGF-1 level occur .</brief_summary>
	<brief_title>Effect Low-Dose Baclofen Administration GH-IGF1 Axis Study</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Patients chronic SCI ( injury great 6 month ) screen find depressed plasma IGF1 level take baclofen . Acute illness etiology , Patients chronic renal , liver , lung , cardiac disease , Patients receive follow medication : narcotic , LDOPA , Alcoholics .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>Baclofen</keyword>
	<keyword>Growth Hormone , Pituitary</keyword>
	<keyword>Insulin-Like Growth Factor I</keyword>
</DOC>